1. Home
  2. News Archive

More News

Vermont Expands ODs’ Scope to Include SLT, LPI, YAG Capsulotomy, Crosslinking
Vermont Expands ODs’ Scope to Include SLT, LPI, YAG Capsulotomy, Crosslinking

Vermont has become the 17th US state to pass a law expanding optometrists’ scope of practice to include in-office laser procedures. Senate Bill 64, signed into law by Gov. Phil Scott on June 18, gr...

Harrow Relaunches Samsung Bioepis’ Biosimilar Byooviz in the US
Harrow Relaunches Samsung Bioepis’ Biosimilar Byooviz in the US

Harrow announced July 1 that it had relaunched Byooviz, a Lucentis biosimilar, in the US. The Nashville, Tennessee, company secured US rights to Byooviz (ranibizumab-nuna) and another ophthalmic bi...

Emerging Companies Pursuing Ophthalmic Indications, July 2026
Emerging Companies Pursuing Ophthalmic Indications, July 2026

Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.

Weekly Surgeon Poll, US Ophthalmologists and Optometrists, July 2026
Weekly Surgeon Poll, US Ophthalmologists and Optometrists, July 2026

Clinical Trial Updates for Ophthalmic Candidates, July 2026
Clinical Trial Updates for Ophthalmic Candidates, July 2026

Market Scope is tracking companies that have announced clinical trial updates or milestone achievements.

July 2026 Ophthalmic News Briefs
July 2026 Ophthalmic News Briefs

Johnson & Johnson reported June 15 that it would invest more than $1 billion in its Jacksonville, Florida, operations to scale US-based manufacturing, packaging, and distribution for its Acuvue con...

US FDA Advisory Panel Will Review Sydnexis’ NDA for SYD-101 in Myopia
US FDA Advisory Panel Will Review Sydnexis’ NDA for SYD-101 in Myopia

Sydnexis announced July 13 that the US FDA would convene an advisory committee meeting to discuss SYD-101, the company’s low-dose atropine candidate for pediatric progressive myopia. The date for t...

US FDA Recalls 2.5 Million Bottles of Prednisolone Acetate Eye Drops
US FDA Recalls 2.5 Million Bottles of Prednisolone Acetate Eye Drops

The US FDA has issued a Class II recall of more than 2.5 million bottles of prednisolone acetate 1% eye drops manufactured by Lupin Limited, citing the possibility of foreign particulate contaminat...

Bausch + Lomb Drops Glaucoma Neuroprotection Program after Phase II Failure
Bausch + Lomb Drops Glaucoma Neuroprotection Program after Phase II Failure

Bausch + Lomb announced July 10 that it would discontinue development of a neuroprotective eye drop candidate for glaucoma, citing Phase II results in which BL1107, a prodrug of brimonidine tartrat...

RxSight Appoints Aziz Mottiwala as President, CEO
RxSight Appoints Aziz Mottiwala as President, CEO

RxSight reported July 15 that it had appointedAziz Mottiwala as president and chief executive officer, effective July 20. Mottiwala succeeds Ron Kurtz, MD, who will continue to serve as chief medic...

J&J Vision Generates Q2-2026 Surgical Revenue of $426 Million
J&J Vision Generates Q2-2026 Surgical Revenue of $426 Million

J&J Vision’s Q2-2026 global surgical revenue totaled $426 million, a 5.6 percent increase over $403 million in Q2-2025, parent Johnson & Johnson, of New Brunswick, New Jersey, reported July 15. Q2-...

Tarsus Acquires iRenix, Developer of Pre-procedure Ocular Antiseptic Candidate
Tarsus Acquires iRenix, Developer of Pre-procedure Ocular Antiseptic Candidate

Tarsus Pharmaceuticals announced July 8 that it had acquired iRenix Medical, of Palo Alto, California, developer of IRX-101, an investigational ocular antiseptic. Tarsus said it would pay approxima...

Tenpoint Submits UK Marketing Application for Yuvezzi Presbyopia Drops
Tenpoint Submits UK Marketing Application for Yuvezzi Presbyopia Drops

Tenpoint Therapeutics reported July 13 that it had submitted a marketing authorization application to the UK’s Medicines and Healthcare Products Regulatory Agency for Yuvezzi (carbachol and brimoni...

Hengrui’s Cyclosporine Eye Drop Formulation for Dry Eye Gains Approval in China
Hengrui’s Cyclosporine Eye Drop Formulation for Dry Eye Gains Approval in China

China’s Hengrui Pharmaceuticals and Germany’s Novaliq announced June 30 that China’s National Medical Products Administration had approved Heng Yi (0.1% cyclosporine ophthalmic solution) for dry ey...

Vivani’s Cortigent to Merge with Nasdaq-Listed ClearOne
Vivani’s Cortigent to Merge with Nasdaq-Listed ClearOne 

Vivani Medical, of Alameda, California, reported July 2 that its Cortigent subsidiary— which is developing the Orion visual cortex implant—would merge with Nasdaq-listed ClearOne to form Cortigent ...

Alcon and RxSight to Collaborate on Developing Adjustable PC-IOLs
Alcon and RxSight to Collaborate on Developing Adjustable PC-IOLs

Alcon and RxSight willjointly develop adjustable presbyopia-correcting intraocular lenses (PC-IOLs) under a new nonexclusive agreement, the companies announced July 6. The collaboration aims to com...

Harrow Relaunches Lucentis Biosimilar Byooviz in the US
Harrow Relaunches Lucentis Biosimilar Byooviz in the US

Harrow announced July 1 that it had relaunched Byooviz (ranibizumab-nuna), a Lucentis biosimilar, in the US. The Nashville, Tennessee, company secured US rights to Byooviz and another ophthalmic bi...

LensCrafters Adds Refractive and Cataract Surgery Options to New Center
LensCrafters Adds Refractive and Cataract Surgery Options to New Center

LensCrafters, part of French company EssilorLuxottica, announced June 30 that it was launching the first LensCrafters Vision & Eye Health Center, addingsurgical procedures and advanced diagnostics ...

US FDA Accepts sBLA for Genentech Subcutaneous TED Candidate, Grants Priority Review
US FDA Accepts sBLA for Genentech Subcutaneous TED Candidate, Grants Priority Review

Genentech announced June 30 that the US FDA had accepted its supplemental biologics license application (sBLA) for subcutaneous Enspryng (satralizumab) in thyroid eye disease (TED). The agency gran...

Global Team of Ophthalmologists Creates Questionnaire for Reporting Dysphotopsias
Global Team of Ophthalmologists Creates Questionnaire for Reporting Dysphotopsias

Twenty multinational ophthalmic specialists, including key opinion leaders, have developed a consensus-based classification system and questionnaire for reporting dysphotopsias after ophthalmic pro...

Bausch + Lomb Rolls Out Orphia Digital Platform, Initially Focused on Patient Education
Bausch + Lomb Rolls Out Orphia Digital Platform, Initially Focused on Patient Education

Bausch + Lomb reported July 9 the introduction of Orphia, a new AI-powered digital health platform intended to increase eye care providers’ efficiency. It will initially provide pre-surgery catarac...

Researchers Develop Dry Eye Candidate Powered by Spinach and Light
Researchers Develop Dry Eye Candidate Powered by Spinach and Light

Researchers in Singapore have developed a spinach-derived nanotechnology that enables corneal cells to produce a key antioxidant molecule when exposed to ambient light. The team at the National Uni...

HelpMeSee Accelerates MSICS Training in India with New Center in Guwahati
HelpMeSee Accelerates MSICS Training in India with New Center in Guwahati

Global nonprofit group HelpMeSee and its Indian subsidiary, HMS Vision Private Limited, have launched virtual training for manual small incision cataract surgery (MSICS) in Guwahati, India. Trainin...

New Marketplace Aims to Rescue Shelved Cell and Gene Therapies
New Marketplace Aims to Rescue Shelved Cell and Gene Therapies

Hundreds of cell and gene therapy (CGT) candidates have been shelved in recent years—not because they failed patients, but because they weren’t considered commercially viable. A new joint venture a...

MACs Propose Limiting Coverage for iDose TR
MACs Propose Limiting Coverage for iDose TR

Five Medicare administrative contractors (MACs) in the US are proposing to limit coverage for procedures implanting the Glaukos iDose TR in patients with glaucoma. The iDose TR is a drug-eluting in...

Viridian Announces US FDA Approval and Launch of Lumvoa for Thyroid Eye Disease
Viridian Announces US FDA Approval and Launch of Lumvoa for Thyroid Eye Disease

Viridian Therapeutics announced June 29 that the US FDA had approved Lumvoa (veligrotug-vvze), an infusion treatment for thyroid eye disease (TED). The Waltham, Massachusetts, company said it would...

Lenz Licenses Vizz Presbyopia Drops to Arrotex for Australia, New Zealand
Lenz Licenses Vizz Presbyopia Drops to Arrotex for Australia, New Zealand

Lenz Therapeutics announced June 24 that it had granted Arrotex Pharmaceuticals exclusive rights to develop Vizz (aceclidine ophthalmic solution) 1.44% eye drops for presbyopia in Australia and New...

LambdaVision Collaborates with Vast, Creator of Planned Commercial Space Station
LambdaVision Collaborates with Vast, Creator of Planned Commercial Space Station

LambdaVision reported June 24 that it had signed a memorandum of understanding with Vast related to future research and manufacturing activities for LambdaVision’s artificial retina aboard Vast’s p...

Supreme Court Ruling in Favor of Bayer May Shut Down Thousands of Roundup Lawsuits
Supreme Court Ruling in Favor of Bayer May Shut Down Thousands of Roundup Lawsuits

German company Bayer won a landmark ruling in the US Supreme Court on June 25, when justices ruled 7-2 that federal pesticide laws preempt “failure-to-warn” claims made under state law. The plainti...

Optos Celebrates Milestone of 30 Thousand Installed Imaging Devices
Optos Celebrates Milestone of 30 Thousand Installed Imaging Devices

UK-based Optos reported June 25 that it had reached the milestone of 30 thousand imaging devices installed globally. The company developed and continues to be a leader in single-capture, 200-degree...

BVI Opens Experience Hub for Ophthalmic Training, Collaboration
BVI Opens Experience Hub for Ophthalmic Training, Collaboration

BVI Medical, of Waltham, Massachusetts, announced June 15 that it had opened a new BVI Experience Hub within its offices in Sant Cugat, Spain. The hub is designed to support ophthalmic training and...

Braille Institute Names Six Recipients of Community Hero Awards
Braille Institute Names Six Recipients of Community Hero Awards

The Braille Institute of America honored six recipients of its Community Hero Awards at a dinner on June 25. The awards recognize extraordinary organizations and leaders for breaking barriers, expa...

Vermont Expands ODs’ Scope to Include SLT, LPI, YAG Capsulotomy, Crosslinking
Vermont Expands ODs’ Scope to Include SLT, LPI, YAG Capsulotomy, Crosslinking

Vermont has become the 17th US state to pass a law expanding optometrists’ scope of practice to include in-office laser procedures. Senate Bill 64, signed into law by Gov. Phil Scott on June 18, gr...

Théa Pharma Launches Zolymbus Bimatoprost Gel for Glaucoma in the US
Théa Pharma Launches Zolymbus Bimatoprost Gel for Glaucoma in the US

Théa Pharma, the Massachusetts-based subsidiary of France-based Théa, announced June 15 that it had launched Zolymbus (bimatoprost ophthalmic gel) 0.01% in the US. Thepreservative-free formulation ...

Hexiris Showcases Glaucoma Devices Targeting Office-Based Surgery
Hexiris Showcases Glaucoma Devices Targeting Office-Based Surgery

Canada’s Hexiris Ophthalmics reports that it is showcasing at ophthalmic meetings its glaucoma device candidates targeting office-based surgery, with an eye toward a commercial launch in 2026. Surg...

EBAA Annual Meeting Underlines Human Impact of Donation
EBAA Annual Meeting Underlines Human Impact of Donation

The 2026 Eye Bank Association of America (EBAA) annual meeting brought together approximately 250 eye bank technicians, medical directors, corneal surgeons, and industry professionals June 3-6 in I...

Formosa Licenses Clobetasol Drops to Samil for Vietnam
Formosa Licenses Clobetasol Drops to Samil for Vietnam

Taiwan-based Formosa Pharmaceuticals announced June 11 that it had expanded its licensing agreement with Samil Pharmaceuticals for clobetasol propionate 0.05% eye drops for postsurgical inflammatio...

Scope Health Adds Vision Support and Eye Comfort Eyetamins to its Optase Product Line
Scope Health Adds Vision Support and Eye Comfort Eyetamins to its Optase Product Line

Scope Health, of New York, announced June 17 that it had added Eyetamins Vision Support and Eye Comfort versions to its Optase line of eyelid hygiene and ocular lubricant products. The Eye Comfort ...

Ocusoft Introduces Retaine Ultra PF Preservative-Free Artificial Tears
Ocusoft Introduces Retaine Ultra PF Preservative-Free Artificial Tears

Ocusoft, of Rosenberg, Texas, announced on June 17 the launch of Retaine Ultra PF, a lubricating eye drop available in a preservative-free multi-dose bottle. Its active ingredients include polyethy...

Essential Pharma Appoints Becki Morison as Chief Executive Officer
Essential Pharma Appoints Becki Morison as Chief Executive Officer

UK-based Essential Pharma announced June 18 that it had appointed Becki Morison as chief executive officer, effective July 1. Morison succeeds Simon Ball, who has served as interim CEO since Novemb...

Aier Eye Hospital Group to Buy 25 VisuMax 800 Lasers from Zeiss
Aier Eye Hospital Group to Buy 25 VisuMax 800 Lasers from Zeiss

German company Carl Zeiss Meditec reported June 17 that the Aier Eye Hospital Group in China had agreed to buy 25 VisuMax 800 femtosecond lasers for its hospital locations starting this year. The V...

Johnson & Johnson to Invest $1 Billion in Jacksonville, Home of J&J Vision
Johnson & Johnson to Invest $1 Billion in Jacksonville, Home of J&J Vision

Johnson & Johnson reported June 15 that it would invest more than $1 billion in its Jacksonville, Florida, operations to scale US-based manufacturing, packaging, and distribution capabilities for i...

Belite Bio Completes Rolling NDA Submission for Oral Tinlarebant in Stargardt
Belite Bio Completes Rolling NDA Submission for Oral Tinlarebant in Stargardt

Belite Bio announced June 12 that it had completed its rolling new drug application (NDA) submission to the US FDA for oral tinlarebant for the treatment of Stargardt disease. The San Diego, Califo...

2026 ARVO Meeting Draws Big Attendance, Rare Snowstorm
2026 ARVO Meeting Draws Big Attendance, Rare Snowstorm

The 2026 meeting of the Association for Research in Vision and Ophthalmology (ARVO) drew 10,996 attendees, the second largest attendance to date, coming in just under the 2024 total of 11,631. The ...

J&J Expands US Rollout of Tecnis PureSee IOL
J&J Expands US Rollout of Tecnis PureSee IOL

Johnson & Johnson reported June 11 that it was expanding availability for the Tecnis PureSee IOL in the US. The lens gained US FDA approval in March 2026. The PureSee is a purely refractive extende...

Alcon Launches Unity CS Phaco System in Canada
Alcon Launches Unity CS Phaco System in Canada

Alcon announced June 15 the launch in Canada of the Unity CS phacoemulsification system for cataract surgery. Alcon said it planned to showcase the platform at the Canadian Ophthalmological Society...

Tavo Biotherapeutics Appoints Federico Grossi, MD, PhD, as CMO
Tavo Biotherapeutics Appoints Federico Grossi, MD, PhD, as CMO

Tavo Biotherapeutics, of Laguna Beach, California, announced June 2 that it had appointed Federico Grossi, MD, PhD, as chief medical officer (CMO). Grossi most recently was CMO of Unity Biotechnolo...

TearSolutions Gains Orphan, Fast Track Status for Lacripep in Neurotrophic Keratitis
TearSolutions Gains Orphan, Fast Track Status for Lacripep in Neurotrophic Keratitis

TearSolutions announced June 2 that the US FDA had granted orphan drug and fast track designations for its synthetic peptide eye drop candidate Lacripep in neurotrophic keratitis (NK). NK is a rare...

Regulatory Changes, Off-Brand Competition Reshape Ophthalmic Market in China
Regulatory Changes, Off-Brand Competition Reshape Ophthalmic Market in China

Continued change is shifting the dynamics of the ophthalmic market in China, boosting revenue growth in some sectors while slowing it in others. Changes are both regulatory and competitive. Regulat...

Ophthalmic Company Revenue Increases 3.7 Percent in First Quarter of 2026
Ophthalmic Company Revenue Increases 3.7 Percent in First Quarter of 2026

Ophthalmic manufacturer revenue in Q1-2026 totaled $11.4 billion. Revenue increased 3.7 percent from the same quarter in 2025 and decreased 2.9 percent from Q4-2025. The total includes Market Scope...

Want to Read Locked Articles?

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.

Select one or more
Select one or more